U.S. Healthtech Stock News

NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

A Look At SolarEdge Technologies (SEDG) Valuation After Recent Share Price Momentum And Mixed Signals

SolarEdge Technologies (NasdaqGS:SEDG) is back on many watchlists after a recent price move, with the stock closing at US$41.76 and short term returns showing mixed performance across the week, month and past 3 months. See our latest analysis for SolarEdge Technologies. The recent pullback, including a 14.34% 7-day share price decline after a strong 30-day and 90-day share price return of 15.71% and 26.97% respectively, comes alongside a very large 1-year total shareholder return and much...
NYSE:OKE
NYSE:OKEOil and Gas

How Analyst Upgrades Amid Geopolitical Tensions Will Impact ONEOK (OKE) Investors

In recent days, ONEOK, Inc. has drawn increased attention after multiple Wall Street firms upgraded their views and highlighted its extensive U.S. natural gas and NGL pipeline network against a backdrop of heightened geopolitical tensions. Public commentary from Jim Cramer further spotlighted the company as a preferred gas name, reinforcing investor focus on its infrastructure footprint and role in supplying global energy markets. We’ll now consider how this wave of analyst upgrades,...
NYSE:MSGE
NYSE:MSGEEntertainment

A Look At Madison Square Garden Entertainment (MSGE) Valuation After New Impossible Foods Partnership

Partnership with Impossible Foods puts food trends in focus for MSGE stock Madison Square Garden Entertainment (MSGE) is in the spotlight after announcing a multiyear partnership with Impossible Foods that introduces a dedicated plant-based concession concept inside The Garden. The agreement ties Impossible Foods branding to New York Knicks and New York Rangers home games and expands plant-based menu options across concourses and premium areas, giving investors a fresh angle on how MSGE...
NYSE:AMPX
NYSE:AMPXElectrical

Is It Too Late To Consider Amprius Technologies (AMPX) After A 7x One-Year Surge?

If you are wondering whether Amprius Technologies at around US$17.22 still offers value after a big run, the answer starts with understanding what the current price is really implying. The stock shows a mixed recent pattern, with a 7.6% gain over the last week, a 7.4% decline over the last month, a 97.0% return year to date, and a very large return of around 7x over the past year. Recent coverage has focused on Amprius Technologies as a high growth name in advanced battery technology, which...
NYSE:AU
NYSE:AUMetals and Mining

AngloGold Ashanti (AU) Is Up 7.9% After Highlighting Arthur Project Reserves And Debt Tender Offers

In recent weeks, AngloGold Ashanti reiterated that its Arthur Gold Project in Nevada is a tier-one deposit with 4.9 million ounces of probable reserves and an expected nine-year mine life, while also launching cash tender offers of up to US$650 million for several outstanding notes. These developments, alongside optimistic earnings projections and supportive analyst sentiment, highlight how the Arthur project and balance sheet actions are becoming central to AngloGold Ashanti’s long-term...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Is It Too Late To Consider Sandisk (SNDK) After A 26x One-Year Surge?

If you are wondering whether Sandisk is still attractively priced after its huge run, or if you might be turning up late, this article walks through what the current share price might be implying about value. Sandisk recently closed at US$851.77, with returns of 21.4% over 7 days, 30.0% over 30 days and 209.5% year to date, while the 1-year return is very large at about 26x. Recent coverage has focused on Sandisk's sharp share price move and what it might indicate about expectations for the...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Assessing Synopsys (SNPS) Valuation After Recent Share Price Weakness

Why Synopsys (SNPS) is on investors’ radar now Synopsys (SNPS) has drawn attention after shares closed at US$392.24, with recent returns showing a month decline of 9.4% and a past 3 months decline of 25.3%. This has prompted closer scrutiny of the company’s fundamentals. See our latest analysis for Synopsys. Beyond the latest pullback, Synopsys has faced a 25.3% 3 month share price decline and an 18.35% year to date share price decline. However, the 5 year total shareholder return of 50.42%...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix’s Push Into Kids’ Gaming and Experiential Partnerships Could Be A Game Changer For Netflix (NFLX)

In early April 2026, Netflix launched Netflix Playground, a stand-alone ad-free kids’ gaming app for subscribers with offline access, while partners like EverPass Media, American Express and Resy expanded their use of Netflix content into live sports broadcasts and immersive Chef’s Table-branded dining events. Together, these moves highlight how Netflix is pushing beyond passive streaming into gaming, live sports, and real-world experiences to deepen engagement with both families and premium...
NYSE:KLAR
NYSE:KLARDiversified Financial

A Look At Klarna Group (KLAR) Valuation After Expanded DOUGLAS Partnership In Southern Europe

Klarna Group (KLAR) is back in focus after expanding its partnership with premium beauty retailer DOUGLAS Group to Italy and Spain, bringing its flexible, interest free installment payment options to more Southern European shoppers. See our latest analysis for Klarna Group. Despite the DOUGLAS expansion and other recent partner wins such as B-Parts, sentiment around Klarna Group has been weak. The 30 day share price return shows a 20.63% decline and the year to date share price return shows a...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Is Reitmans’ Shift to Shopify (SHOP) Hinting at a Deeper Edge in Enterprise Retail?

In early April 2026, Reitmans Canada Ltd. announced it had completed migrating the e-commerce operations of Reitmans, RW&CO., and Penningtons to Shopify, aiming to deliver a faster, more intuitive digital shopping experience across its brands. This move highlights how larger apparel retailers are increasingly standardizing their online operations on Shopify’s infrastructure to unify customer experiences and streamline digital commerce. We’ll now explore how Reitmans’ multi-brand migration to...
NYSE:IFF
NYSE:IFFChemicals

International Flavors & Fragrances (IFF) Valuation Check After New Probiotic And Soy Protein Health Claim

International Flavors & Fragrances (IFF) just announced two science-backed product milestones: a canine probiotic called PureStrong and a heart health claim for its isolated soy protein in Australia and New Zealand, broadening its reach across pet care and nutrition. See our latest analysis for International Flavors & Fragrances. The latest product news lands as the share price sits at $72.52, with a 30-day share price return of 5.53% and a 1-year total shareholder return of 1.52%. The 5-year...
NasdaqGS:WWD
NasdaqGS:WWDAerospace & Defense

A Look At Woodward (WWD) Valuation After Aerospace Growth And Rising Sector Momentum

Woodward (WWD) is back in focus after its Aerospace segment delivered a 29% revenue surge in Q1 2026, supported by higher commercial services activity and a 23% rise in defense OEM sales. See our latest analysis for Woodward. Those quarterly aerospace numbers come on top of strong market interest, with a 90 day share price return of 20.65% and a 1 year total shareholder return of 132.75%, suggesting momentum has been building rather than fading. If you are looking for more ideas in adjacent...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave Anthropic Deal Expands AI Client Mix And Capacity Story

CoreWeave, NasdaqGS:CRWV, has signed a multi year AI cloud infrastructure agreement with Anthropic. The deal extends CoreWeave’s client roster beyond Meta and adds another top tier AI model provider to its customer base. The partnership brings CoreWeave to nine of the top ten AI model providers as clients, addressing recent concerns about customer concentration. For investors watching CoreWeave, NasdaqGS:CRWV, this Anthropic deal sits alongside a share price of $102.0 and recent returns of...
NasdaqGS:MDLN
NasdaqGS:MDLNMedical Equipment

Medline’s First FDA Warning Tests Quality Controls And Growth Story

Medline (NasdaqGS:MDLN) has received an FDA warning letter citing manufacturing deficiencies in its angiographic syringe production. The letter, the first major regulatory challenge since Medline went public, focuses on quality and compliance issues with potential patient safety implications. The FDA action requires Medline to address identified problems and document corrective steps before the matter can be closed. For investors following Medline at a share price of $45.6, this FDA warning...
NYSE:VOYA
NYSE:VOYADiversified Financial

How Investors May Respond To Voya Financial (VOYA) Q1 Buyback And Alternative Investment Income Update

In early 2026, Voya Financial reported that it repurchased 2,068,788 shares in Q1 for US$150 million, completing a buyback program totaling 205,118,034 shares and US$9.87 billion since its launch in March 2014, while also estimating preliminary Q1 alternative investment income of US$35 million to US$45 million pre-tax. These repurchases and the alternative investment income update highlight how Voya is actively using its balance sheet to return capital while signaling how its investment...
NasdaqGS:CENX
NasdaqGS:CENXMetals and Mining

A Look At Century Aluminum (CENX) Valuation As Industry Support And Analyst Optimism Build

What is driving renewed attention on Century Aluminum? Century Aluminum (CENX) has moved back into focus as supply disruptions tied to the Iran war push US billet premiums higher, while US trade policy enforcement targets tariff loopholes that previously benefited some importers. At the same time, several analyst firms have reiterated or raised positive views on the company, citing these policy moves and expectations for tighter aluminum supply. Together, these factors are shaping how...
NYSE:T
NYSE:TTelecom

Is It Time To Reconsider AT&T (T) After Mixed Recent Share Price Moves

Wondering if AT&T at around US$26.46 is a bargain or just fairly priced? This section will help you work out whether the current price lines up with the underlying business. The stock has had a mixed run recently, with a 6.6% decline over the past week and a 2.6% decline over the past month, while still showing a 7.7% gain year to date and a 3.1% return over the last year. Recent attention on AT&T has focused on its role as a major U.S. telecom provider and how its scale, customer base, and...
NYSE:GM
NYSE:GMAuto

Is GM's (GM) Camaro Revival a Strategic Recommitment to Profitable ICE Platforms Over Pure EV Focus?

In recent days, General Motors confirmed it will revive the Chevrolet Camaro for the 2027/2028 model years, while also expanding its sedan lineup by building the new Camaro, Cadillac CT5, and a returning Buick sedan on a shared second-generation Alpha platform at the Lansing Grand River plant. This move marks a clear bet on higher-margin performance and internal combustion vehicles alongside ongoing EV efforts, using a common architecture to improve manufacturing efficiency and broaden the...
NYSE:WHR
NYSE:WHRConsumer Durables

Is Whirlpool (WHR) Share Weakness Creating A Long Term Value Opportunity?

If you are wondering whether Whirlpool's current share price reflects its true worth, you are not alone and the numbers give plenty to think about. The stock most recently closed at US$56.51, with a 7 day return of 1.9%, a 30 day return of a 3.0% decline, and longer term returns of a 24.1% decline year to date and a 26.4% decline over 1 year. Over the past 3 years Whirlpool has recorded a 49.7% decline and over 5 years a 68.9% decline, which frames the current share price in a very different...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Can Veeva Systems (VEEV) Turn High Margins And Partnerships Into Lasting Competitive Strength?

In recent months, Veeva Systems reported strong profitability with operating margins near 28.7% and free cash flow margins above 40%, while also announcing a partnership in the past with RegASK to link its Regulatory Information Management platform to near-real-time regulatory intelligence. These updates highlight a business that is highly cash-generative yet facing softer billings growth and rising competitive pressure, even as it leans on product innovation and ecosystem partnerships to...
NYSE:LLY
NYSE:LLYPharmaceuticals

Assessing Eli Lilly (LLY) Valuation After A 13% Year To Date Share Price Pullback

What recent returns say about Eli Lilly (LLY) Eli Lilly (LLY) has seen mixed share performance recently, with a 1.6% decline in the past day, a small gain over the past week, and declines over the past month and past 3 months. Year to date, the stock shows a 13.0% decline. The 1 year, 3 year, and 5 year total returns remain positive, giving investors a wide range of entry points depending on their time horizon. See our latest analysis for Eli Lilly. The recent 13.0% year-to-date share price...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

Assessing ASML Holding (NasdaqGS:ASML) Valuation After Strong Share Price Momentum

Why ASML Holding (NasdaqGS:ASML) is Back on Investors’ Radar ASML Holding (NasdaqGS:ASML) has attracted renewed attention after a strong 1 year total return of 123%, alongside reported annual revenue of €32,667.3m and net income of €9,609.4m. These figures highlight its role in semiconductor equipment. See our latest analysis for ASML Holding. ASML Holding’s share price is up 12.23% over the past week and 16.05% over the past 90 days, with a 27.02% year to date share price return and a...
NYSE:MPLX
NYSE:MPLXOil and Gas

How Investors Are Reacting To MPLX (MPLX) Softer Segment Forecasts And Valuation Discount

In recent days, analysts have updated their views on MPLX ahead of its 5 May 2026 earnings release, with consensus now expecting earnings per share of $1.07 and revenue of $3.14 billion, alongside revised segment forecasts reflecting commodity price shifts and Winter Storm Fern impacts. Despite softer near-term earnings expectations and identified headwinds in Natural Gas and NGL Services, brokerage sentiment remains broadly positive, with an overall Outperform recommendation and MPLX...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Hamilton Lane Credit Income Fund Targets Wealth Demand For Private Credit

Hamilton Lane (NasdaqGS:HLNE) has received SEC approval for its new Credit Income Fund. The interval fund, part of the firm's Evergreen Platform, is expected to become available to investors this month. The launch expands Hamilton Lane's private credit offering for individual and wealth clients. The firm now offers twelve Evergreen vehicles spanning different private markets strategies. Hamilton Lane focuses on private markets investment solutions, with growing attention on products that...